2017 first half results presentation

Operating revenues, growth data, profitability and the behavior of our products.


No votes yet
 
Related
Total revenue amounted to 357.0 million euros in the first half of 2026, up 13.2% compared to 315.3 million euros in the same period of...
4 min
23/07/2026
Today, Laboratorios Farmacéuticos ROVI, S.A. (“ROVI”) has signed a Protocol of Intentions with the Regional Government of Castilla-La...
3 min
08/07/2026
​Total revenue in the first quarter of 2026 amounted to 154.7 million euros, in line with the same period of the previous year....
4 min
06/05/2026